The effects of passive antibodies on protection and active immune responses to human rotavirus were studied in gnotobiotic pigs. Pigs were injected at birth with saline or sow serum of high (immunized) or low (control) antibody titre and subsets of pigs were fed colostrum and milk from immunized or control sows. Pigs were inoculated at 3-5 days of age and challenged at 21 days post-inoculation (p.i.) with virulent Wa human rotavirus. Pigs receiving immune serum with or without immune colostrum/milk were partially protected against diarrhoea and virus shedding after inoculation, but had significantly lower IgA antibody titres in serum and small intestinal contents at 21 days p.i. and lower protection rates after challenge compared with pigs given control or no maternal antibodies. IgG antibody titres were consistently higher in small than in large intestinal contents. Pigs given control serum with control colostrum/milk had lower rates of virus shedding after inoculation than those given control serum alone. In summary, high titres of circulating maternal antibodies with or without local (milk) antibodies provided passive protection after inoculation but suppressed active mucosal antibody responses. These findings may have implications for the use of live, oral rotavirus vaccines in breast-fed infants. Vietnam 0001-6057 # 1999 SGM BEBH Downloaded from www.microbiologyresearch.org by
Introduction
Group A rotaviruses are the principal cause of severe gastroenteritis and diarrhoea in infants worldwide (Bern & Glass, 1994 ; Ryan et al., 1996 ; Barnes et al., 1998) . Rotaviruses are estimated to cause 873 000 deaths per year in children in developing countries and 3n5 million cases of diarrhoea in the USA, with 20 deaths per year (Marwick, 1998 ; Parashar et al., 1998) . Annual economic losses due to hospitalization of infants with rotavirus-induced disease in the USA have been estimated to be over 1 billion dollars .
The worldwide impact of rotavirus infections has prompted efforts to control the disease by using oral vaccination strategies. Several oral vaccines have been developed based on heterologous host rotaviruses, attenuated human rotavirus (HRV) and human-animal rotavirus reassortants. A tetravalent human-rhesus reassortant rotavirus vaccine was effective in reducing rotavirus-induced diarrhoea in trials in the USA and Finland (Bernstein et al., 1995 ; Joensuu et al., 1997 ; Rennels et al., 1996 ; Ward et al., 1997) but was less effective in trials in some developing countries (Lanata et al., 1996 ; Linhares et al., 1996) . The reduced efficacy may reflect the lower vaccine dose used in these latter trials (4i10% vs 4i10& p.f.u.) (Perez-Schael et al., 1997) , differences in titres of maternal antibodies (Rimer et al., 1992) , differences in exposure to rotavirus before and during the vaccination process (Joensuu et al., 1997 ; Lanata et al., 1996 ; Linhares et al., 1996) or differences in trial design (Perez-Schael et al., 1997) .
The determinants of protective active immunity to rota-virus are not well understood, but many reports indicate that intestinal IgA antibodies are important for immunity to rotavirus and resistance to symptomatic re-infection (Coulson et al., 1990 (Coulson et al., , 1992 Matson et al., 1993 ; Bishop et al., 1996 ; Yuan et al., 1996 ; Johansen & Svensson, 1997) . In humans, circulating passive rotavirus antibodies acquired transplacentally or milk rotavirus antibodies acquired by breast-feeding may contribute to the asymptomatic rotavirus infections observed in neonates (Vial et al., 1988 ; Flores et al., 1994) . Breast-fed or orally administered milk immunoglobulins (Igs) have been reported to protect against rotavirus-induced diarrhoea (Clemens et al., 1993 ; Turner & Kelsey, 1993) . However, in oral rotavirus vaccine trials, higher pre-vaccination antibody titres in serum and cord blood have been associated with lower rates of seroconversion after vaccination (Friedman et al., 1993 ; Ward et al., 1997) . The reported effect of breast feeding on immune responses to oral vaccination is inconsistent but there is a trend toward lower seroconversion rates in breast-fed infants (Pichichero, 1990 ; Glass et al., 1991 ; Rimer et al., 1992 ; Rennels, 1996) . The suppressive effect of maternal antibodies may be more important in developing countries, where lower vaccine efficacies have been observed in vaccine trials in Thailand (Migasena et al., 1995) , Peru (Lanata et al., 1996) , Brazil (Linhares et al., 1996) and Venezuela (Rimer et al., 1992 ; Vesikari, 1997) . Rimer et al. (1992) reported higher rotavirus antibody titres in breast milk from Venezuelan mothers than in milk from mothers in New York State and used logistic regression to demonstrate the suppressive effects of both milk and serum antibodies on seroconversion rates following oral rotavirus vaccination. Thus, circulating and milk antibodies, although contributing to passive immunity against rotavirus infection, may impair the development of active immunity and decrease the efficacy of live oral rotavirus vaccines. The gnotobiotic pig model has several advantages over other animal models for studies of passive immunity to HRV. In comparison with mice and calves, the intestinal tract physiology, body size, type of passive immunity (milk IgA) and immune development of piglets resemble those of human infants more closely. Pigs are susceptible to HRV infection and produce subsequent diarrhoea and the gnotobiotic environment prevents natural exposure to rotavirus or other diarrhoeal pathogens that could confound data analysis. In addition, pigs are born devoid of maternal antibodies, acquiring serum Igs by intestinal absorption of colostrum Igs for up to 36 h after birth before gut closure (cessation of absorption of intact Ig) occurs (Banks & McGuire, 1989) , facilitating experimental manipulation of levels of passive antibodies.
The aim of this study was to investigate the role of circulating maternal antibodies without colostrum\milk (mimicking bottle-fed infants) or with colostrum\milk (mimicking breast-fed infants) in passive protection against rotavirusinduced diarrhoea and the effects of such passive antibodies on the development of active antibody responses in a gnotobiotic pig model of rotavirus disease.
Methods
Human rotavirus. The Wa strain of HRV (P1A[8], G1), obtained from an infant stool specimen, was serially passaged in gnotobiotic pigs and the median pig infectious dose was determined as described previously (Wyatt et al., 1980 ; Schaller et al., 1992 ; Ward et al., 1996 b) . A virus suspension consisting of pooled intestinal contents from the 16th passage was used as virulent HRV for pig inoculation and challenge. The virus was diluted in minimal essential medium (Eagle's MEM ; Gibco) containing 100 IU\ml penicillin, 0n1 mg\ml dihydrostreptomycin and 0n14 % (w\v) NaHCO $ . A monkey kidney (MA-104) cell culture lysate containing the 27th passage of the attenuated, cell culture-adapted Wa HRV (Wyatt et al., 1980 ; Ward et al., 1996 b) was used for sow immunization to produce immune serum, colostrum and milk and as antigen in the isotype-specific ELISA. Virus infectivity titres were determined by a cell culture immunofluorescence (CCIF) assay in MA-104 cells (Bohl et al., 1982) .
Immune and control sow serum, colostrum and milk. Two pregnant, rotavirus-seropositive (naturally infected) sows were immunized intramuscularly (i.m.) five or six times at 2 week intervals with " 1i10( fluorescent focus units (FFU) attenuated Wa HRV in incomplete Freund's adjuvant (IFA) and twice orally with " 5i10' FFU virulent Wa HRV, two weeks apart. After the last immunization, the serum was collected, pooled and filtered through a 0n22 µm membrane filter and stored at k20 mC until use. Sera from non-immunized (n l 2) or adjuvant alone (IFA)-immunized (five or six times i.m.), rotavirusseropositive (n l 2) sows in the same herd were used as the control sow sera. Immune colostrum and milk were obtained from 10 pregnant, rotavirus-seropositive sows inoculated i.m. at 4, 3 and 2 weeks before farrowing with " 1i10( FFU attenuated Wa HRV emulsified in IFA. The colostrum was collected at farrowing (200-500 ml per sow) and milk was obtained from day 4 until 5-10 days post-parturition. After collection, the colostrum and milk were centrifuged at 700 g for 45 min at 4 mC to remove fat and cells, inactivated at 56 mC for 30 min and centrifuged at 10 000 g for 20 min to remove casein. Finally, the samples were sterilized chemically by using 0n3% β-propiolactone with agitation for 1 h at 37 mC. Colostrum and milk samples from 10 control, rotavirusseropositive sows in the same herd were collected and processed in an identical manner (see Table 1 ).
Experimental design and gnotobiotic pigs. Hysterectomyderived, near-term pigs were assigned to nine groups and housed in sterile isolation units as described previously (Meyer et al., 1964) . Pigs were maintained under gnotobiotic conditions and fed a commercial modified infant formula (Ross Laboratories) as the basic diet. Within the first 24 h after birth, the pigs were injected intraperitoneally (i.p.) with 60 ml sow serum in two inoculations of 30 ml 12 h apart. Preliminary studies showed that the administration of this volume of sow serum in the newborn gnotobiotic pig resulted in piglet serum IgG concentrations (18-26 mg\ml) similar to the range reported in naturally suckled piglets (25-40 mg\ml) (Ward et al., 1996 a) . Subsets of pigs were given 60 ml sow serum of high antibody titre, group 1 (immune serum, n l 26) and group 2 (immune serumjimmune colostrum\milk, n l 12), or 60 ml sow serum with low antibody titre, group 3 (control serum, n l 17) and group 4 (control serumjcontrol colostrum\milk, n l 11). The diet of group 2 pigs was supplemented with 30 ml immune colostrum daily from 2-4 days of age and 50 ml immune milk for 10 days (5-14 days of age). The diet of group 4 pigs was supplemented in the same manner but with control colostrum and milk. Group 5 (no maternal antibodies, n l 58) pigs were injected i.p. with 60 ml saline solution or not injected. At Table 1 . VN and isotype-specific ELISA antibody titres to Wa HRV in the sow maternal-antibody sources Sows were immunized with Wa HRV (Immune) or adjuvant alone (Control) as described in Methods. Ratio I\C, ratio of antibody titre in pooled Immune samples to titre in pooled Control samples. 3-5 days of age, pigs from each group received 5 ml 100 mM sodium bicarbonate to reduce gastric acidity and 10 min later were inoculated orally with 5i10& FFU (5i10& ID &! ) virulent Wa HRV (Ward et al., 1996 b ; Yuan et al., 1996) . Thirteen age-matched gnotobiotic pigs that received control (n l 6) or immune (n l 7) sow serum and 14 that received control serum plus colostrum\milk (n l 7) or immune serum plus colostrum\milk (n l 7) were mock-inoculated with 5 ml diluent and served as unexposed controls. At day 21 post-inoculation (p.i.), the pigs were challenged with 5i10' FFU (5i10' ID &! ) virulent Wa HRV (Yuan et al., 1996 ; Ward et al., 1996 b) . All pigs were bled weekly after inoculation. Selected pigs from each group (n l 2-6) were euthanized at day 0, 7, 21\0, 25\4 and 28\7 p.i.\post-challenge (p.c.) and serum, small intestinal contents (SIC) and large intestinal contents (LIC) were collected. Serum samples were processed as described previously . The SIC and LIC samples were diluted 1 : 2 in Eagle's MEM, treated with 250 µg\ml trypsin inhibitor (Sigma) and 50 µg\ml leupeptin (Sigma) to inhibit enzymatic digestion and stored at k20 mC until assayed.
BEBI
Analysis of clinical signs. All pigs were observed daily for clinical signs of infection. Rectal swabs were collected daily after inoculation and challenge. Faecal consistency was scored as follows : 0, normal ; 1, pasty ; 2, semi-liquid and 3, liquid. Faeces with scores 2 were considered diarrhoeic. Rotavirus shedding was detected in the rectal swab fluids by using an antigen-capture ELISA (Saif et al., 1983) and CCIF assay (Bohl et al., 1982) as described previously.
Plaque-reduction virus-neutralization assay.
A plaque-reduction virus-neutralization assay was used to determine the virusneutralizing (VN) antibody titre to Wa HRV in sow serum, colostrum and milk whey and in pig serum, as described previously (Saif et al., 1983 ; Yuan et al., 1996 ; Fernandez et al., 1998) . The VN antibody titres were expressed as the reciprocal of the highest sample dilution in which the plaque number was reduced by 80 %.
Isotype-specific antibody ELISA.
To determine the isotypespecific antibody titres to Wa HRV in serum, LIC and SIC samples from gnotobiotic pigs, an indirect isotype-specific antibody ELISA was used (Fernandez et al., 1998 ; with several modifications. Briefly, 96-well plates (NUNC-Maxisorp) were coated overnight at 4 mC with a guinea pig hyperimmune serum against group A rotavirus in carbonatebicarbonate buffer (pH 9n6) and blocked with 1 % BSA (ICN Biomedicals). Plates were washed four times with 0n5 % Tween 20 in PBS, pH 7n4, prior to the addition of 100 µl of each reagent\sample per well and incubated for 1 h at 37 mC. Semi-purified Wa HRV or mock-infected MA-104 cell supernatant fluids were added in volumes of 100 µl. Serial 4-fold dilutions (initial dilution of 1 : 4) of each test sample were assayed in antigen-coated or mock antigen-coated wells and the following sequence of reagents was then added : biotinylated MAbs (from ascites) against porcine IgG, IgA or IgM (diluted 1 : 30 000, 1 : 20 000 and 1 : 5000, respectively) (Paul et al., 1989) ; horseradish peroxidase-conjugated streptavidin (diluted 1 : 40 000) (KPL) ; and 0n05 % ABTS [2,2h-azino-bis (3-ethylbenz-thiazoline-6-sulfonate)] substrate. The reaction was stopped with 50 µl 5 % SDS. The A %"% was read by using an ELISA plate-reader (Flow Titretek Multiskan, Flow Laboratories). The ELISA antibody titre of each sample was expressed as the reciprocal of the highest dilution that had a corrected A %l% value (sample absorbance in the virus-coated well minus sample absorbance in the mock antigen-coated well) greater than the cut-off value (mean corrected A %l% of negative controlsj3 SD). A positive control of known antibody titre and four negative control samples were run in each plate. Samples negative at a dilution of 1 : 4 were assigned a titre of 1 : 2 for the calculation of geometric mean titres (GMTs). 
Statistical

Results
VN and isotype-specific ELISA antibody titres of sow maternal antibody sources
Antibody titres of pooled sow serum, colostrum and milk samples are summarized in Table 1 . VN antibody titres in pooled immune serum, colostrum and milk from immunized sows were 28-, 2n6-and 3n4-fold higher than the corresponding pooled samples from control sows. High VN antibody titres were associated with high IgG antibody titres in serum and colostrum from the immune sows. No or low IgA antibody titres, respectively, were found in the pooled immunized and non-immunized sow serum samples. Significant differences in VN and ELISA antibody titres were observed between pigs from the immune (groups 1 and 2) and control (groups 3 and 4) groups at day 0 p.i. (Table 2 ). No significant differences were observed between the serum antibody titres of pigs receiving immune serum alone (group 1) and those of pigs receiving immune serum plus immune colostrum\milk (group 2) or between the serum antibody titres of pigs receiving control * Significance of differences between groups were determined by Fisher's exact test. Values in a given column with the same superscript letter do not differ significantly. † Data obtained post-challenge for mock-inoculated groups receiving the same serum preparations were combined for statistical analysis since the numbers of animals were low and the data were comparable. serum alone (group 3) and those of pigs receiving control serum plus control colostrum\milk (group 4) at day 0 p.i.
Protection after inoculation and challenge
Clinical data from this study have been presented previously (Hodgins et al., 1999) and are summarized briefly in Table 3 . Among group 1 (immune serum) and 2 (immune serum j colostrum\milk) pigs, 33 % developed diarrhoea after inoculation. The rates of diarrhoea for groups 1 and 2 were similar to those of age-matched, mock-inoculated pigs (groups 1a and 2a). In contrast, over 90 % of pigs in groups 3 (control serum), 4 (control serumjcolostrum\milk) and 5 (no maternal antibodies) had diarrhoea after inoculation. The rates of diarrhoea of these three groups were significantly greater than for groups 1 and 2.
The proportions of pigs shedding virus after inoculation in groups 1, 2 and 4 were significantly less than for groups 3 and 5. Among pigs that shed virus after inoculation, mean peak virus titres in faeces were lowest for groups 1 and 2, but differences among the five groups were not significant (data not shown).
After challenge exposure to virulent Wa rotavirus at day 21 p.i., of the five principal groups, group 2 had the highest rate of diarrhoea, followed by groups 1, 4, 3 and 5. The rates of diarrhoea did not differ significantly among the latter four groups but were significantly higher for group 2 when compared with group 5. Group 5 (no maternal antibodies) had a significantly lower rate (12 %) of diarrhoea than the mockinoculated pigs (94 %), all of which shed virus. Groups 3 and 5 were fully protected from virus shedding following challenge. In contrast, 17-20 % of pigs in groups 1, 2 and 4 shed virus. Among pigs that shed virus after challenge, the peak titres of shed virus did not differ significantly (data not shown).
Isotype-specific ELISA antibody responses to Wa HRV
The Wa HRV antibody isotype-specific titres in serum, SIC and LIC samples of pigs killed at each time-point are shown in Figs 1 and 2. A summary of VN and isotype-specific antibody responses in serum of pigs alive at day 0 p.i., day 21 p.i.\0 p.c. and day 7 p.c. is shown in Table 2 . Seroconversion rates after inoculation and challenge are shown in Table 4 .
IgG antibody. IgG serum antibody titres in pigs receiving immune serum and immune serum plus colostrum\milk (groups 1 and 2, respectively) were significantly higher than in groups 3, 4 and 5 from day 0 p.i. to day 4 p.c. ; serum titres declined slowly over the duration of the experiment. For groups 3 and 4 (control serum and control serum plus colostrum\milk, respectively), serum IgG antibody titres were moderate at day 0 p.i. (GMT 194 and 373, respectively) and increased after inoculation (GMT 1217 and 3250, respectively) and challenge (GMT 8192 and 16 384, respectively) . At challenge (day 21 p.i.\0 p.c.), IgG antibody titres in groups 3 and 4 were lower (GMT 1217 and 3250, respectively) than in group 5 (no maternal antibodies, GMT 16 384), but not significantly so. No seroconversion for IgG antibody was detected in group 1 and 2 pigs after inoculation or challenge. After inoculation, 50 and 67 %, respectively, of group 3 and 4 pigs seroconverted with IgG antibodies. Of those pigs that did not seroconvert after inoculation, 33 % (group 3) and 100 % (group 4) seroconverted after challenge. All group 5 pigs seroconverted with IgG antibody after inoculation. None of the mock-inoculated pigs seroconverted with IgG antibody after mock inoculation or by day 7 p.c. (data not shown).
Moderate titres of IgG antibodies (GMT 32-1024) were detected in the SIC of group 1 and 2 pigs throughout the experiment. IgG antibody titres in SIC of group 3 and 4 pigs were low to undetectable at all time-points ; GMTs were lower than those of group 5 pigs at day 8 p.i. and significantly lower after day 8 p.i.
The IgG antibody titres were minimal or undetectable in the LIC of group 1, 2, 3 and 4 pigs at all time-points tested ; mean titres in group 5 pigs (no maternal antibodies) were higher in LIC from day 8 p.i. onwards and significantly higher after challenge.
IgA antibody. IgA antibodies were detected in serum of group 5 pigs at day 8 p.i. but were not detected in groups 1 and 2 * Means in a given column with different superscripts are statistically different (P 0n05) ; means with the same superscript do not differ significantly (Fisher's exact text, two-tailed).
Differences between percentages post-challenge were not significant because of the small number of animals tested.
until day 7 p.c. (Table 2) . At day 21 p.i., IgA serum antibodies were significantly higher in group 5 (GMT 3250) than in groups 3 and 4 (GMT 362 and 143, respectively), which were in turn significantly higher than in groups 1 and 2 (undetectable) . No seroconversion for IgA antibodies was detected in group 1 and 2 pigs after inoculation but 67 % of pigs in both groups seroconverted by day 7 p.c. (Table 4 ). After inoculation, 75 and 50 %, respectively, of group 3 and 4 pigs seroconverted with IgA antibodies. Those pigs in groups 3 and 4 that did not seroconvert after inoculation seroconverted after challenge. All group 5 pigs seroconverted with IgA antibodies after inoculation. None of the mock-inoculated pigs seroconverted with IgA antibodies after mock inoculation ; 13 % seroconverted after challenge (data not shown).
IgA antibodies were undetectable in the SIC or LIC of group 1 and 2 pigs throughout the experiment (Fig. 1) , with the exception of low titres in group 2 at day 8 p.i., while these pigs were still receiving milk supplements containing high titres of IgA antibodies. In group 5, IgA antibodies were detected in SIC at day 8 p.i. ; by day 21 p.i. titres were significantly higher than those of group 3, which were in turn significantly higher than those of group 4. IgA antibodies were detected in LIC of group 5 pigs by day 8 p.i. ; titres at day 21 p.i. were higher than those of group 3 and significantly higher than those of group 4.
IgM antibody. A vigorous serum IgM response (GMT 65 539) occurred in group 5 pigs by day 8 p.i. The IgM antibody GMTs for groups 1, 2, 3 and 4 were significantly lower at day 8 p.i. (GMT 16-256) and did not exceed 425 at any time (Fig.  1) . No seroconversion for IgM antibody was detected in group 1 and 2 pigs after inoculation but 50 % and 67 %, respectively, seroconverted by day 7 p.c. After inoculation, 75 % and 50 %, respectively, of group 3 and 4 pigs seroconverted with IgM antibodies ; of those pigs that did not seroconvert after inoculation, none seroconverted after challenge. All group 5 pigs seroconverted with IgM antibodies after inoculation. The majority (88 %) of mock-inoculated pigs seroconverted with IgM antibodies after challenge (data not shown).
The IgM antibody titres in the SIC and LIC of group 5 pigs were low at day 8 p.i. (GMT 108) and declined thereafter. The IgM antibody titres in the SIC and LIC were higher in group 5 than in group 4 and significantly higher than those of groups 1, 2 and 3 at day 8 p.i. Mock-inoculated pigs (groups 1a, 2a, 3a and 4a ; Fig. 2 ) developed IgM antibody responses in LIC and SIC by day 7 p.c., consistent with primary immune responses.
Discussion
Gnotobiotic pigs were used as a model to investigate the role of passive antibodies, present in the circulation or locally (colostrum and milk), in protection and active antibody responses against rotavirus. Pigs were injected with pooled serum with high (group 1) or low (group 3) antibody titres to mimic formula-fed infants with circulating antibodies acquired Maternal antibodies to Wa human rotavirus Maternal antibodies to Wa human rotavirus from mothers with high or low antibody titres, respectively. Pigs in groups 2 and 4 were fed colostrum\milk of high or low antibody titre, respectively (in addition to the serum administered i.p.) to mimic passive immunity in breast-fed infants. Pigs were inoculated with virulent Wa HRV to simulate primary natural exposure in the presence of passive antibodies. Twenty-one days later, the pigs were challenged to evaluate the effect of maternal antibodies on development of active immune responses and protection on re-exposure.
Groups 1 and 2, with high titres of circulating maternal antibodies, had significant protection against HRV-induced diarrhoea (comparable rates of diarrhoea to mock-inoculated pigs) and were partially protected against virus shedding after inoculation (50-64 % of pigs shed virus). These results are consistent with findings for conventional pigs (Ward et al., 1996 a) and calves (Besser et al., 1988 b) , where high IgG antibody titres in serum conferred protection against severe rotavirus-induced diarrhoea. In the present study, IgG antibodies were detected consistently in the SIC but not in the LIC of groups 1 and 2, suggesting possible transfer of IgG from the serum into the small, but not the large, intestine. In HRVinoculated pigs, IgG antibodies could be transudated from the circulation into the small intestine after local infection and tissue damage (Ward et al., 1996 b) . However, the presence of comparable titres of IgG antibodies in the SIC of mockinoculated pigs at day 21 p.i. suggests that transfer of serum IgG into the small intestine was not dependent on infection and inflammation. Besser et al. (1988 a, b) documented the transfer of IgG1 antibodies from the circulation to the gut of neonatal calves and Ward et al. (1996 a) suggested that a comparable mechanism may exist in neonatal pigs. The absence of detectable IgG antibodies in the LIC may be due to enzymatic degradation of IgG or to limited transfer of serum IgG antibodies into this region, or both. In human neonates, rotavirus infections are often asymptomatic (Vial et al., 1988 ; Flores et al., 1994) and high titres of circulating IgG antibodies acquired transplacentally may play a role in the passive protection of newborn infants (Flores et al., 1994) . It is unclear whether a mechanism of IgG transport from the serum to the intestine, comparable to that demonstrated in calves, exists in humans but high titres of immunologically active Fab fragments have been noted in the stools of 1-week-old, formula-fed infants (Quan et al., 1996) . These fragments were derived from serum IgG of the mother and had high affinity for their corresponding antigen (tetanus toxoid).
In the present study, high titres of IgG maternal antibodies in serum were associated with suppression of both IgM and IgA antibody responses after inoculation. The absence of a serum IgM response in the presence of passive antibodies has also been reported in experiments with measles virus in a macaque model (van Binnendijk et al., 1997) . Flores et al. (1994) noted that 27-33 % of infants with high maternal VN antibody titres in cord blood did not seroconvert with IgA antibodies after rotavirus infection.
After challenge, groups 1 and 2 had higher rates of diarrhoea and virus shedding than group 5, but not significantly so. However, groups 1 and 2 had significantly lower rates of virus shedding compared with age-matched, mock-inoculated, rotavirus-challenged pigs. These results indicate that even in the presence of high titres of circulating IgG maternal antibodies, groups 1 and 2 developed modified immune responses that mediated at least partial protection against reinfection. As reported elsewhere (Hodgins et al., 1999) , although reduced numbers of both IgA and IgG antibodysecreting cells (ASC) were present in the duodenum and ileum of group 1 pigs after challenge, even fewer ASC were present in the intestines of group 2 pigs. Cell-mediated immune responses may be contributing to the observed active protection in these groups, as cell-mediated immune responses appear to be less susceptible to the suppressive effects of passive antibodies than humoral responses (van Binnendijk et al., 1997) . The partial immunity observed in groups 1 and 2 following secondary exposure after asymptomatic primary infection agrees with the observation of several groups (Bishop et al., 1983 ; Ward & Bernstein, 1994 ; Velazquez et al., 1996) , that even asymptomatic rotavirus infections can contribute to protection against severe disease following re-infection.
After challenge, groups 1 and 2 developed significantly lower IgA antibody titres in serum and intestinal secretions compared with groups 3, 4 and 5. These results indicate a suppressive effect of maternal antibodies, not only on primary, but also on secondary antibody responses. In results reported elsewhere (Hodgins et al., 1999) , significantly lower numbers of IgA ASC were found in intestinal tissues of groups 1 and 2 after challenge compared with group 5. Interference by maternal antibodies may explain the need for two or more rotavirus infections (symptomatic or asymptomatic) to provide protection against moderate to severe diarrhoea in Mexican children (Velazquez et al., 1996) . Lanata et al. (1996) have reported that in Peru, three doses of oral rotavirus vaccine (4i10% p.f.u. per dose) did not increase vaccine efficacy compared with one dose (efficacies of 35-66 % against severe diarrhoea), whereas Perez-Schael et al. (1997) found in Venezuela that three doses of 4i10& p.f.u. had 88 % efficacy against severe rotavirus-induced diarrhoea, comparable to clinical trials in the USA and Finland. An additive suppressive effect of local milk antibodies, beyond the suppressive effect of circulating antibodies alone, on active ASC responses in intestinal tissues has been reported elsewhere (Hodgins et al., 1999) .
After inoculation, pigs receiving control serum only (group 3) were not protected against rotavirus-induced diarrhoea or virus shedding. Similar results were reported by Ward et al. (1996 a) , where low levels of circulating maternal antibodies did not protect conventional pigs against porcine rotavirus infection and disease after challenge. These investigators, however, did not follow active IgM and IgA responses in serum or intestinal contents. In the present study, group 3 IP: 54.70.40.11
On: Sat, 22 Dec 2018 10:21:29 V. Parren4 o and others V. Parren4 o and others developed significantly lower active IgA antibody titres and slightly lower rates of IgA seroconversion than pigs with no maternal antibodies (75 % vs 100 %, respectively) after inoculation, indicating a suppressive effect of maternal antibodies even at low titres. However, all group 3 pigs had seroconverted with IgA antibodies by day 7 p.c. and were protected similarly to group 5 against virus shedding and diarrhoea after challenge.
Pigs receiving both control serum and colostrum\milk (group 4) had significantly lower rates of virus shedding after inoculation compared with groups 3 and 5 (although rates of diarrhoea were similar), indicating an at least partially protective effect by low titres of local passive antibodies, probably due to virus neutralization by the local milk antibodies. Schaller et al. (1992) reported that orally administered bovine colostral antibodies (without passive serum antibodies) passively protected pigs against HRV challenge in a dose-dependent manner. Similarly, Bishop et al. (1996) reported a higher prevalence of rotavirus infection in formula-fed than in breastfed infants. Group 4 pigs also developed significantly lower primary IgA antibody responses in intestinal fluids at day 21 p.i. and lower IgA antibody seroconversion rates compared with group 3 and 5 pigs, suggesting an additive suppressive effect conferred by local milk antibodies. These findings concur with results of human vaccine trials, where breast-fed infants have lower rates of seroconversion than formula-fed infants (Pichichero, 1990 ; Rimer et al., 1992 ; Glass et al., 1996 ; Rennels et al., 1996) . At challenge, groups with higher titres of IgA in the SIC had higher rates of protection against diarrhoea and virus shedding, confirming that intestinal IgA is a good marker for protection against rotavirus infection (Coulson et al., 1992 ; Matson et al., 1993 ; Bishop et al., 1996 ; Yuan et al., 1996) .
In conclusion, high titres of circulating maternal antibodies with or without colostrum\milk antibodies conferred partial protection against Wa HRV after primary inoculation ; however, these passive antibodies suppressed primary and secondary active antibody responses significantly. Low titres of passive circulating antibodies did not confer protection against rotavirus infection and diarrhoea but did reduce primary active IgA antibody responses. Low titres of lactogenic antibodies in the presence of low titres of circulating antibodies conferred partial protection against HRV shedding but not diarrhoea and had an additive suppressive effect on development of primary active IgA immune responses in the intestines. Thus, new vaccine strategies may be needed to stimulate protective active immune responses (especially IgA) in the presence of the high titres of maternal antibodies that occur in infants in developing countries. Both microencapsulation (Periwal et al., 1997) and immune stimulating complexes (ISCOMS) (van Binnendijk et al., 1997) show promise in this regard.
